Total Payments
$7,718
2024 Payments
$6,706
Companies
8
Transactions
34
Medicare Patients
2,381
Medicare Billing
$290,090

Payment Breakdown by Category

Consulting$7,071 (91.6%)
Food & Beverage$646.73 (8.4%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $7,071 27 91.6%
Food and Beverage $646.73 7 8.4%

Top Paying Companies

Company Total Records Latest Year
Regeneron Pharmaceuticals, Inc. $3,853 5 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $2,732 22 $0 (2024)
Eli Lilly and Company $500.00 1 $0 (2018)
Janssen Biotech, Inc. $249.88 2 $0 (2024)
Ardelyx, Inc. $148.71 1 $0 (2023)
Regeneron Healthcare Solutions, Inc. $118.73 1 $0 (2023)
AbbVie Inc. $97.26 1 $0 (2023)
Laborie Medical Technologies Corp. $18.24 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $6,706 29 Regeneron Pharmaceuticals, Inc. ($3,853)
2023 $511.55 4 Ardelyx, Inc. ($148.71)
2018 $500.00 1 Eli Lilly and Company ($500.00)

All Payment Transactions

34 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
11/10/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $55.00 General
11/10/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $24.10 General
11/07/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $225.80 General
11/07/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $197.38 General
11/07/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $197.38 General
11/07/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $139.28 General
11/07/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $122.54 General
11/07/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $122.54 General
11/07/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $73.00 General
11/07/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $48.98 General
11/07/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $48.95 General
11/07/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $39.97 General
11/07/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $33.97 General
11/07/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $33.97 General
11/07/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $19.65 General
11/07/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $19.65 General
11/07/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $19.65 General
10/18/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $548.00 General
10/18/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $26.89 General
10/11/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $411.18 General
10/11/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $288.98 General
10/11/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $35.00 General
10/08/2024 Janssen Biotech, Inc. TREMFYA (Drug), STELARA Food and Beverage In-kind items and services $103.03 General
Category: Immunology
10/01/2024 Laborie Medical Technologies Corp. alpHaONE (Device) Food and Beverage Cash or cash equivalent $18.24 General
Category: Gastroenterology
09/19/2024 Regeneron Pharmaceuticals, Inc. DUPIXENT (Biological) Consulting Fee Cash or cash equivalent $2,094.00 General
Category: INFLAMMATION AND IMMUNOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 12 508 552 $716,608 $62,027
2022 14 618 648 $786,696 $74,476
2021 16 663 742 $862,039 $82,927
2020 17 592 665 $624,727 $70,661
Total Patients
2,381
Total Services
2,607
Medicare Billing
$290,090
Procedure Codes
59

All Medicare Procedures & Services

59 procedure records from CMS Medicare Utilization — Page 3 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99443 Physician telephone patient service, 21-30 minutes of medical discussion Office 2020 21 27 $4,158 $2,572 61.9%
43251 Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope Facility 2020 14 14 $28,210 $2,339 8.3%
99203 New patient office or other outpatient visit, typically 30 minutes Office 2020 27 27 $15,552 $2,316 14.9%
45385 Removal of polyps or growths of large bowel using an endoscope Facility 2020 14 14 $33,754 $2,161 6.4%
43235 Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope Facility 2020 19 19 $26,125 $1,877 7.2%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 24 27 $10,962 $1,804 16.5%
99231 Subsequent hospital inpatient care, typically 15 minutes per day Facility 2020 29 42 $7,140 $1,426 20.0%
45378 Diagnostic examination of large bowel using an endoscope Facility 2020 11 11 $19,833 $1,360 6.9%
99204 New patient office or other outpatient visit, typically 45 minutes Office 2020 11 11 $7,975 $1,300 16.3%

About Dr. Guy Weiss, M.D

Dr. Guy Weiss, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Buffalo, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2010. The National Provider Identifier (NPI) number assigned to this provider is 1598084030.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Guy Weiss, M.D has received a total of $7,718 in payments from pharmaceutical and medical device companies, with $6,706 received in 2024. These payments were reported across 34 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($7,071).

As a Medicare-enrolled provider, Weiss has provided services to 2,381 Medicare beneficiaries, totaling 2,607 services with total Medicare billing of $290,090. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.

Practice Information

Products in Payments

  • DUPIXENT (Biological) $3,972
  • IBSRELA (Drug) $148.71
  • STELARA (Biological) $146.85
  • TREMFYA (Drug) $103.03
  • RINVOQ (Biological) $97.26
  • alpHaONE (Device) $18.24

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Buffalo